Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Abstracts for the British Association of Dermatologists 101st Annual Meeting, Virtual Meeting

Issue Information

Free Access

Issue Information

  • Pages: 1-2
  • First Published: 06 July 2021

Foreword

Free Access

Foreword

J. Ingram, 
  • Page: 3
  • First Published: 06 July 2021

Officers and Committee

Free Access

Officers and Committee

  • Page: 4
  • First Published: 06 July 2021

Vice President

Free Access

Vice President

  • Page: 5
  • First Published: 06 July 2021

Guest Speakers

Free Access

Guest Speakers

  • Pages: 6-7
  • First Published: 06 July 2021

Orals

Free Access

O01: The impact of the COVID-19 pandemic on people with psoriasis: findings from a global patient-reported registry

  • Page: 8
  • First Published: 06 July 2021
Free Access

O02: Doxycycline in the management of bullous pemphigoid: real-world data from a specialist centre

  • Pages: 8-9
  • First Published: 06 July 2021
Free Access

O03: A randomized controlled trial to compare the efficacy and safety of apremilast and methotrexate in patients with palmoplantar psoriasis

  • Page: 9
  • First Published: 06 July 2021
Free Access

O04: The burden of immune-mediated skin disease in inpatients with HIV/AIDS

  • Pages: 9-10
  • First Published: 06 July 2021
Free Access

O06: Dapsone therapy for hidradenitis suppurativa: a retrospective review of characteristics and treatment outcomes in 122 patients in a tertiary dermatology setting over the last 6 years

  • Pages: 10-11
  • First Published: 06 July 2021
Free Access

O07: Efficacy of abrocitinib monotherapy in patients with prior exposure to systemic treatments: pooled results from the JADE MONO-1 and JADE MONO-2 studies

  • Page: 11
  • First Published: 06 July 2021
Free Access

O08: The epidemiology of alopecia areata: a population-based cohort study in UK primary care

  • Pages: 11-12
  • First Published: 06 July 2021
Free Access

O09: Abstract withdrawn

  • Page: 12
  • First Published: 06 July 2021
Free Access

O10: The Green Initiative: improving environmentally sustainable practice and optimizing waste management in a dermatology department

  • Pages: 12-13
  • First Published: 06 July 2021

Registrar papers

Free Access

RF01

  • Page: 13
  • First Published: 06 July 2021
Free Access

RF02: Mosaic BRAF fusions are a recurrent cause of multiple congenital melanocytic naevi

  • Page: 13
  • First Published: 06 July 2021
Free Access

RF03: A UK case series of BRCA1-associated protein-1 inactivated melanocytic tumours from a tertiary referral centre: a marker for familial melanoma

  • Page: 14
  • First Published: 06 July 2021
Free Access

RF04: Seven important criteria for the diagnosis of psoriasis in children: the results of a large UK multicentre diagnostic accuracy study (DIPSOC study)

  • Pages: 14-15
  • First Published: 06 July 2021
Free Access

RF05: Uraemic pruritus: examining the symptom and its management in haemodialysis patients

  • Page: 15
  • First Published: 06 July 2021
Free Access

RF06

  • Page: 15
  • First Published: 06 July 2021

Clinicopathological cases

Free Access

CPC01: Neutrophilic eccrine hidradenitis secondary to antipsychotic use

  • Pages: 15-16
  • First Published: 06 July 2021
Free Access

CPC02: Myeloma-associated light-chain amyloidosis presenting with nail dystrophy and scleroderma-like skin changes

  • Page: 16
  • First Published: 06 July 2021
Free Access

CPC03: A presentation of symmetrical drug-related intertriginous and flexural exanthema associated with postexposure prophylaxis

  • Pages: 16-17
  • First Published: 06 July 2021
Free Access

CPC04: IgA pemphigus, lymphomatoid papulosis and anaplastic large-cell lymphoma presenting in the same patient: is there a link or is it bad luck?

  • Page: 17
  • First Published: 06 July 2021
Free Access

CPC05: An unusual case of comedones

  • Pages: 17-18
  • First Published: 06 July 2021
Free Access

CPC06: Oral mycosis fungoides: a rare clinical entity

  • Page: 18
  • First Published: 06 July 2021
Free Access

CPC07: Solving a SOX10 riddle: an unusual and rare case of malignant triton tumour mimicking melanoma

  • Pages: 18-19
  • First Published: 06 July 2021
Free Access

CPC08: A case of cutaneous malakoplakia: a pain in the neck

  • Page: 19
  • First Published: 06 July 2021
Free Access

CPC09: Scurvy masquerading as bullous cutaneous vasculitis in an institutionalized patient

  • Pages: 19-20
  • First Published: 06 July 2021
Free Access

CPC10: Mediterranean masquerade: clinicopathogenetic analysis of an unusual presentation

  • Page: 20
  • First Published: 06 July 2021
Free Access

CPC11: An unusual case of vulval ulceration

  • Pages: 20-21
  • First Published: 06 July 2021
Free Access

CPC12: Eosinophilic dermatosis of haematological malignancy

  • Page: 21
  • First Published: 06 July 2021
Free Access

CPC13: Two cases of trimethoprim-induced drug reaction with eosinophilia and systemic symptoms

  • Pages: 21-22
  • First Published: 06 July 2021
Free Access

CPC14: Histological and direct immunofluorescence pattern in Schamberg disease: an analytical study

  • Page: 22
  • First Published: 06 July 2021

Health service delivery, management research and Getting It Right First Time (GIRFT) symposium

Free Access

GIRFT01: Money matters: assessing the value of the adalimumab biosimilar switch plan for dermatology patients

  • Pages: 22-23
  • First Published: 06 July 2021
Free Access

GIRFT02: Identifying and addressing barriers to referral to a regional psychodermatology service

  • Page: 23
  • First Published: 06 July 2021
Free Access

GIRFT03: What is the role of a specialist hair clinic? The impact and patient experience of a regional specialist hair clinic run within a National Health Service

  • Pages: 23-24
  • First Published: 06 July 2021
Free Access

GIRFT04: An analysis of referrals to a paediatric dermatology national care centre: how many could be managed in primary care?

  • Page: 24
  • First Published: 06 July 2021

Free Access

GIRFT05: Inpatient care for skin disease is an essential part of National Health Service provision

  • Pages: 24-25
  • First Published: 06 July 2021
Free Access

GIRFT06: Dermatology high-cost drug management: pharmacists getting it right first time in COVID-19

  • Page: 25
  • First Published: 06 July 2021

Posters

Free Access

P01: A rare case of cutaneous collagenous vasculopathy in a young man

  • Page: 26
  • First Published: 06 July 2021
Free Access

P02: A case of porokeratosis of Mibelli extending into a graft site

  • Page: 26
  • First Published: 06 July 2021
Free Access

P04: A case of metastatic mesothelioma of the scalp and literature review

  • Page: 27
  • First Published: 06 July 2021
Free Access

P05: Bullous disease of dialysis in a patient with end-stage renal failure on haemodialysis with subsequent complete resolution of symptoms post-renal transplant

  • Page: 27
  • First Published: 06 July 2021
Free Access

P06: A nontender, well-circumscribed nodule on the left forehead

  • Page: 28
  • First Published: 06 July 2021
Free Access

P07: Muir–Torre syndrome associated with treatment-resistant actinic keratosis and microsatellite instability

  • Page: 28
  • First Published: 06 July 2021
Free Access

P08: Nodular vasculitis disclosing a diagnosis of covert multisystem tuberculosis

  • Pages: 28-29
  • First Published: 06 July 2021
Free Access

P09: Unusual clinical variant of pemphigus foliaceous responding to dapsone in skin of colour

  • Page: 29
  • First Published: 06 July 2021
Free Access

P10: Multiple eruptive dermatofibromas in an immunocompetent patient

  • Pages: 29-30
  • First Published: 06 July 2021
Free Access

P11: Phytophotodermatitis-induced bullous pemphigoid

  • Page: 30
  • First Published: 06 July 2021
Free Access

P12: Treatment of primary cutaneous mucormycosis due to Absidia corymbiferia in a patient with systemic lupus erythematosus and lupus nephritis

  • Pages: 30-31
  • First Published: 06 July 2021
Free Access

P13: Clinicopathological correlation to the rescue: two unusual presentations of a common inflammatory disorder

  • Page: 31
  • First Published: 06 July 2021
Free Access

P14: Agminated Spitz naevi arising within a speckled lentiginous naevus: a clue to a common pathogenesis

  • Pages: 31-32
  • First Published: 06 July 2021
Free Access

P15: Dermatology in skin of colour: the experience of UK dermatologists

  • Page: 32
  • First Published: 06 July 2021
Free Access

P16: An assessment of the experiences of general practitioners and general practitioner trainees of referrals to paediatric dermatology services

  • Pages: 32-33
  • First Published: 06 July 2021

Free Access

P17: Measurement properties of the Cardiff Acne Disability Index (CADI): 28 years of global clinical experience

  • Page: 33
  • First Published: 06 July 2021
Free Access

P18: Audit of infectious complications in erythrodermic mycosis fungoides/Sézary syndrome

  • Page: 33
  • First Published: 06 July 2021
Free Access

P19: Cutaneous manifestations of COVID-19 in the UK: a registry of digital submissions from interdisciplinary healthcare professionals

  • Page: 34
  • First Published: 06 July 2021
Free Access

P20: Understanding dermatological concerns in people experiencing homelessness: a scoping review and discussion for improved delivery of care

  • Page: 34
  • First Published: 06 July 2021
Free Access

P21: Practising dermatology in the era of COVID-19: a tertiary centre’s experience of adapting to change

  • Pages: 34-35
  • First Published: 06 July 2021
Free Access

P22: The effectiveness of educational programmes in promoting sun protection in children under the age of 18 years: a systematic review and meta-analysis

  • Page: 35
  • First Published: 06 July 2021
Free Access

P23: Referring wisely: an analysis of the appropriateness of in-hours referral to dermatology within a London teaching hospital

  • Pages: 35-36
  • First Published: 06 July 2021
Free Access

P24: Dermatology medical student history taking via the telephone: a way to minimize disruption to medical education, particularly during a pandemic

  • Page: 36
  • First Published: 06 July 2021
Free Access

P25: The impact of the second wave of the COVID-19 pandemic on the quality of life of patients with skin cancer

  • Pages: 36-37
  • First Published: 06 July 2021
Free Access

P26: Using the Vitiligo Noticeability Scale in clinical trials and clinical practice: construct validity, interpretability, reliability and acceptability

  • Page: 37
  • First Published: 06 July 2021
Free Access

P27: Healthcare resource use and cost in patients treated with dupilumab in English hospitals

  • Pages: 37-38
  • First Published: 06 July 2021
Free Access

P28: The effects of COVID-19 on undergraduate dermatology training: a qualitative study

  • Page: 38
  • First Published: 06 July 2021
Free Access

P29: Routine screening with early-morning cortisol facilitates identification and improves management of adrenal insufficiency in glucocorticoid-treated dermatology patients

  • Pages: 38-39
  • First Published: 06 July 2021
Free Access

P30: Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink

  • Page: 39
  • First Published: 06 July 2021
Free Access

P31: Use of omics technology for the identification of critical mediators and pathways in patients with hidradenitis suppurativa

  • Pages: 39-40
  • First Published: 06 July 2021
Free Access

P32: Mucosal-associated invariant T cells and interleukin-17 lineage in hidradenitis suppurativa

  • Page: 40
  • First Published: 06 July 2021
Free Access

P33: Gliflozin-induced vulval psoriasis

  • Page: 40
  • First Published: 06 July 2021
Free Access

P34: Reduction in the incidence of dupilumab-induced ocular surface disease by a preventative topical eye treatment regime

  • Page: 41
  • First Published: 06 July 2021
Free Access

P35: The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are nonpublished trials being overlooked?

  • Pages: 41-42
  • First Published: 06 July 2021
Free Access

P36: Calciphylaxis: a regional review

  • Page: 42
  • First Published: 06 July 2021
Free Access

P38: Mental health of patients with psoriasis during the COVID-19 pandemic: a cross-sectional study in a tertiary setting

  • Pages: 42-43
  • First Published: 06 July 2021
Free Access

P39: Real-world disease characteristics and treatment patterns in patients with atopic dermatitis in the UK: results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey

  • Page: 43
  • First Published: 06 July 2021
Free Access

P40: Positive indirect immunofluorescence pemphigoid antibodies: a clinicopathological analysis

  • Pages: 43-44
  • First Published: 06 July 2021
Free Access

P41: Are psoriasis and eczema mutually exclusive diseases? A systematic review

  • Page: 44
  • First Published: 06 July 2021
Free Access

P42: Decreased risk of rheumatic skin diseases in HIV/AIDS

  • Pages: 44-45
  • First Published: 06 July 2021
Free Access

P43: Desmoplasia in cutaneous squamous cell carcinoma with perineural invasion

  • Page: 45
  • First Published: 06 July 2021
Free Access

P44: Dermatological issues in the transgender population: a review of the literature

  • Pages: 45-46
  • First Published: 06 July 2021
Free Access

P45: The good, the bad and the ugly: inflammation in epidermolysis bullosa wounds

  • Pages: 46-47
  • First Published: 06 July 2021
Free Access

P46: Occupational dermatoses during COVID-19: effect on work and wellbeing

  • Page: 47
  • First Published: 06 July 2021
Free Access

P47: Improving treatment outcomes for leprosy in Pernambuco, Brazil: a qualitative study exploring the experiences and perceptions of retreatment patients and their carers

  • Pages: 47-48
  • First Published: 06 July 2021
Free Access

P48: Growing burden of dermatophytosis in southern region of Nepal

  • Page: 48
  • First Published: 06 July 2021
Free Access

P49: Toxic epidermal necrolysis in the setting of systemic lupus erythematosus: a case series

  • Page: 48
  • First Published: 06 July 2021
Free Access

P50: A randomized controlled trial of integrative cognitive behavioural therapy for patients with alopecia areata: a pilot study

  • Page: 49
  • First Published: 06 July 2021
Free Access

P51: Socioeconomic factors influence severity rather than incidence of dermatoses

  • Page: 49
  • First Published: 06 July 2021
Free Access

P52: A virtual multidisciplinary clinic service for the diagnosis and treatment of severe perianal skin disease in hidradenitis suppurativa and Crohn disease

  • Pages: 49-50
  • First Published: 06 July 2021
Free Access

P53: Toxic shock syndrome in paediatric burn patients and the implication of silver-based dressings

  • Page: 50
  • First Published: 06 July 2021
Free Access

P54: Potential impact of remote consultations in primary care on teledermatology and 2-week wait (2WW) suspected skin cancer referrals: the need for a range of innovative approaches for pre-2WW triage

  • Pages: 50-51
  • First Published: 06 July 2021
Free Access

P55: A noninvasive screening tool for the detection of melanoma in a publicly available ISIC dataset using a single parameter in hue saturation values space

  • Page: 51
  • First Published: 06 July 2021
Free Access

P56: A systematic review and meta-analysis of total body photography for the diagnosis of cutaneous melanoma in adults

  • Pages: 51-52
  • First Published: 06 July 2021
Free Access

P57: Surprising trends in the detection of cutaneous malignancy during the COVID-19 pandemic

  • Page: 52
  • First Published: 06 July 2021
Free Access

P58: A screening study of distress levels in patients attending a skin cancer clinic

  • Pages: 52-53
  • First Published: 06 July 2021
Free Access

P59: Identifying the correct patients at risk of melanoma requiring long-term digital monitoring

  • Page: 53
  • First Published: 06 July 2021
Free Access

P60: Suspicion of melanoma: a retrospective study of patterns of patient presentation leading to new diagnoses

  • Pages: 53-54
  • First Published: 06 July 2021
Free Access

P61: Pattern of chemotherapeutic adverse effects in patients with malignancies

  • Page: 54
  • First Published: 06 July 2021
Free Access

P62: An increase in Breslow thickness: coronavirus or coincidence?

  • Page: 54
  • First Published: 06 July 2021
Free Access

P63: Eliminating wrong-site surgery with digital photography: quality-improvement project

  • Page: 55
  • First Published: 06 July 2021
Free Access

P64: The incident rates of keratinocyte cancer at locations of previously treated squamous cell carcinoma in situ

  • Pages: 55-56
  • First Published: 06 July 2021
Free Access

P65: Retrospective analysis of the safety and appropriate use of 2,3-diphenylcyclopropenone in alopecia in a university teaching hospital

  • Page: 56
  • First Published: 06 July 2021
Free Access

P66: Prolonged symptom control with long-term ligelizumab treatment in patients with chronic spontaneous urticaria during post-treatment follow-up

  • Pages: 56-57
  • First Published: 06 July 2021
Free Access

P67: High rate of complete response with ligelizumab in adults with moderate-to-severe chronic spontaneous urticaria

  • Pages: 57-58
  • First Published: 06 July 2021
Free Access

P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD

  • Pages: 57-58
  • First Published: 06 July 2021
Free Access

P69: Implementing therapeutic drug monitoring of adalimumab in psoriasis: from theory to practice

  • Pages: 58-59
  • First Published: 06 July 2021
Free Access

P70: Real-world effectiveness of guselkumab in achieving absolute PASI thresholds and mean DLQI scores in patients with moderate-to-severe plaque psoriasis: analysis of the BADBIR registry following 6 months of treatment

  • Page: 59
  • First Published: 06 July 2021
Free Access

P71: Demographics and drug survival in patients with psoriasis treated with brodalumab enrolled in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR) up to 1 year

  • Page: 60
  • First Published: 06 July 2021
Free Access

P72: Alitretinoin for chronic hand eczema in two dermatology centres: assessing real-world use and predictors of response

  • Pages: 60-61
  • First Published: 06 July 2021
Free Access

P73: A novel approach to systemic monitoring in a pandemic

  • Page: 61
  • First Published: 06 July 2021
Free Access

P74: Comparative evaluation of the efficacy and safety of dermabrasion followed by a prostaglandin E2 analogue (dinoprostone) versus dermabrasion followed by tacrolimus ointment 0·1% in localized stable vitiligo

  • Page: 61
  • First Published: 06 July 2021
Free Access

P75: Hydroxychloroquine in inflammatory oral mucosal conditions

  • Pages: 61-62
  • First Published: 06 July 2021
Free Access

P76: Long-term oral prednisolone exposure in primary care for bullous pemphigoid: a population-based study

  • Page: 62
  • First Published: 06 July 2021
Free Access

P77: Ixekizumab in the BADBIR registry: baseline characteristics, continuation with ixekizumab and disease activity at first follow-up in different subgroups of patients with psoriasis

  • Pages: 62-63
  • First Published: 06 July 2021
Free Access

P78: Comparison of efficacy and safety ‘apremilast’, psoralen photochemotherapy and methylprednisolone oral minipulse in unstable nonsegmental vitiligo

  • Page: 63
  • First Published: 06 July 2021
Free Access

P79: A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre

  • Page: 63
  • First Published: 06 July 2021
Free Access

P80: A systematic review of laser treatment of verrucous epidermal naevi

  • Page: 64
  • First Published: 06 July 2021
Free Access

P81: Real-world response to dupilumab in patients with atopic dermatitis: a retrospective review of 100 patients

  • Page: 64
  • First Published: 06 July 2021

Global Health Dermatology

Free Access

GD01: Leprosy-related disability in India: highlighting the gender gap

  • Page: 65
  • First Published: 06 July 2021
Free Access

GD02: Fiji albinism project: raising awareness and destigmatizing albinism in Fiji

  • Page: 65
  • First Published: 06 July 2021
Free Access

GD03: Pellagra in low-income settings: can we prevent it?

  • Pages: 65-66
  • First Published: 06 July 2021
Free Access

GD04: Not the usual cyst

  • Page: 66
  • First Published: 06 July 2021

British Association of Dermatologists Dermatology and Genetic Medicine (BADGEM)

Free Access

BG01: Hair/tooth ectodermal dysplasia type 14 without hypohidrosis caused by biallelic TSPEAR variants

  • Page: 67
  • First Published: 06 July 2021
Free Access

BG02: Muir-Torre syndrome: a case of unusual coexisting genetic mutations

  • Pages: 67-68
  • First Published: 06 July 2021
Free Access

BG03: Multifocal rhabdomyomas in a patient with Birt–Hogg–Dubé syndrome

  • Page: 68
  • First Published: 06 July 2021
Free Access

BG04: Computer-aided quantification of palmar hyperlinearity in atopic dermatitis: a proof-of-concept study

  • Pages: 68-69
  • First Published: 06 July 2021
Free Access

BG05 (P45): The good, the bad and the ugly: inflammation in epidermolysis bullosa wounds

  • Page: 69
  • First Published: 06 July 2021
Free Access

BG06: The phenotypic spectrum of biallelic plectin mutations: findings from the UK epidermolysis bullosa database

  • Pages: 69-70
  • First Published: 06 July 2021
Free Access

BG07: The protean impact of WNT10A mutations on ectodermal structure and function

  • Page: 70
  • First Published: 06 July 2021
Free Access

BG08: JEBseq: a novel database to explore genotype–phenotype correlation in junctional epidermolysis bullosa

  • Pages: 70-71
  • First Published: 06 July 2021
Free Access

BG09: A homozygous intronic mutation in UNC13D in type 3 familial haemophagocytic lymphohistiocytosis: pathogenic insights regarding subcutaneous panniculitis-like T-cell lymphoma

  • Page: 71
  • First Published: 06 July 2021
Free Access

BG10: Heterozygous frameshift mutation in glomulin causing autosomal dominant familial glomuvenous malformation with associated intracranial cavernoma

  • Page: 72
  • First Published: 06 July 2021
Free Access

BG11: Vulval intraepithelial neoplasia and early squamous cell carcinoma development in a patient with Netherton syndrome

  • Pages: 72-73
  • First Published: 06 July 2021
Free Access

BG12: Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: 3-month results of the phase III ‘EASE’ study

  • Page: 73
  • First Published: 06 July 2021
Free Access

BG13: A review of oral retinoid therapy for patients with inherited disorders of keratinization attending tertiary referral genodermatosis services

  • Pages: 73-74
  • First Published: 06 July 2021
Free Access

BG14: Unilateral multiple facial angiofibromas as a solitary manifestation of tuberous sclerosis

  • Page: 74
  • First Published: 06 July 2021
Free Access

BG15: Sebaceous papules in hypohidrotic ectodermal dysplasia: a paradoxical finding

  • Pages: 74-75
  • First Published: 06 July 2021

British Cosmetic Dermatology Group

Free Access

BC01 (P44): Dermatological issues in the transgender population: a review of the literature

  • Page: 76
  • First Published: 06 July 2021
Free Access

BC02 (P80): A systematic review of laser treatment of verrucous epidermal naevi

  • Page: 76
  • First Published: 06 July 2021
Free Access

BC03: Facial subcision and SkulptraTM cosmetic fillers: a damaging combination?

  • Page: 77
  • First Published: 06 July 2021
Free Access

BC04: Apocrine chromhidrosis of the bilateral cheeks

  • Page: 77
  • First Published: 06 July 2021
Free Access

BC05: Irritant blepharitis from eyelash extensions in the context of isotretinoin therapy: time to lash it on the patient information leaflet?

  • Pages: 77-78
  • First Published: 06 July 2021
Free Access

BC06: Efficacy of lasers and light-based devices in long-term hair reduction defined by body site-specific growth cycles: a systematic review

  • Page: 78
  • First Published: 06 July 2021
Free Access

BC07: Self-injected fillers: a case of severe pustular reaction with a review of the scale of the problem

  • Pages: 78-79
  • First Published: 06 July 2021

British Hair and Nail Society

Free Access

BH01: Fibrosing alopecia in a pattern distribution: clinicopathological features and treatment response in 26 patients

  • Page: 80
  • First Published: 06 July 2021
Free Access

BH02: Recalcitrant scalp disease in dermatomyositis

  • Page: 80
  • First Published: 06 July 2021
Free Access

BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia

  • Pages: 80-81
  • First Published: 06 July 2021
Free Access

BH04 (P35): The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are nonpublished trials being overlooked?

  • Page: 81
  • First Published: 06 July 2021
Free Access

BH05: Nondermatophyte onychomycosis and paronychia secondary to Aspergillus niger

  • Pages: 81-82
  • First Published: 06 July 2021
Free Access

BH06 (P65): Retrospective analysis of the safety and appropriate use of 2,3-diphenylcyclopropenone in alopecia in a university teaching hospital

  • Page: 82
  • First Published: 06 July 2021
Free Access

BH07: Testosterone deficiency in men with female pattern hair loss

  • Pages: 82-83
  • First Published: 06 July 2021
Free Access

BH08: A rare and incidental finding of pili multigemini of the back

  • Page: 83
  • First Published: 06 July 2021
Free Access

BH10: Central cicatricial centrifugal alopecia or something else?

  • Pages: 83-84
  • First Published: 06 July 2021

British Photodermatology Group

Free Access

PD01: A randomized single-blinded prospective study to compare short incubation white light-emitting diode photodynamic therapy (PDT) with conventional PDT for the treatment of squamous cell carcinoma in situ

  • Page: 85
  • First Published: 06 July 2021
Free Access

PD02: A prospective objective pilot study to assess the relationship between protoporphyrin IX fluorescence and skin surface temperature during photodynamic therapy

  • Pages: 85-86
  • First Published: 06 July 2021
Free Access

PD03: Development of a validated self-report questionnaire of facial photoprotection in xeroderma pigmentosum

  • Page: 86
  • First Published: 06 July 2021
Free Access

PD04: Solar urticaria: a systematic review of clinical features and natural history in 851 cases

  • Page: 86
  • First Published: 06 July 2021
Free Access

PD05: Skin safety and efficacy of filtered far ultraviolet C for SARS-CoV-2 inactivation

  • Page: 87
  • First Published: 06 July 2021
Free Access

PD06 (P26): Using the Vitiligo Noticeability Scale in clinical trials and clinical practice: construct validity, interpretability, reliability and acceptability

  • Page: 87
  • First Published: 06 July 2021
Free Access

PD07: Prescribing and using vitiligo treatments for limited active vitiligo: lessons from a nested process evaluation within the HI-Light Vitiligo randomized controlled trial

  • Page: 88
  • First Published: 06 July 2021
Free Access

PD08: Patient-reported outcomes and phototherapy preassessment: an introduction to a new mobile phone-based system

  • Page: 88
  • First Published: 06 July 2021
Free Access

PD09 (P79): A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre

  • Page: 89
  • First Published: 06 July 2021
Free Access

PD10: Light penetration into a six-layer skin model for 200–1000 nm

  • Page: 89
  • First Published: 06 July 2021
Free Access

PD11: Access to phototherapy during the COVID-19 pandemic

  • Pages: 89-90
  • First Published: 06 July 2021
Free Access

PD12: Daylight photodynamic therapy at home

  • Page: 90
  • First Published: 06 July 2021
Free Access

PD13: Beliefs and attitudes to sun tanning and knowledge of melanoma in the Irish population: a cross-sectional study

  • Pages: 90-91
  • First Published: 06 July 2021
Free Access

PD14: Treating field cancerization in a time of COVID-19: daylight photodynamic therapy is effective, socially distant and satisfactory to our most vulnerable patients

  • Page: 91
  • First Published: 06 July 2021
Free Access

PD15: Erythropoietic protoporphyria: the challenges and stigma of an invisible disease

  • Pages: 91-92
  • First Published: 06 July 2021
Free Access

PD16: Behaviours, attitudes and the importance of sun safety via an Arduino development kit

  • Page: 92
  • First Published: 06 July 2021

British Society for Cutaneous Allergy

Free Access

CD01: An association between tosylamide/formaldehyde resin and formaldehyde contact allergy? Changing trends in allergic contact dermatitis to tosylamide/formaldehyde resin across a 38-year period from a tertiary dermatology centre

  • Page: 93
  • First Published: 06 July 2021
Free Access

CD02: Cutaneous reactions to glucose sensors: is the problem stuck with us?

  • Pages: 93-94
  • First Published: 06 July 2021
Free Access

CD03: Benzisothiazolinone: new kid on the block

  • Page: 94
  • First Published: 06 July 2021
Free Access

CD04: Sudocrem dermatitis: easily missed

  • Page: 94
  • First Published: 06 July 2021
Free Access

CD05: Contact allergy in patients with lichen planus

  • Pages: 94-95
  • First Published: 06 July 2021
Free Access

CD06: A case of pseudoangioimmunoblastic T-cell lymphoma due to a failed shoulder replacement

  • Page: 95
  • First Published: 06 July 2021
Free Access

CD07: A survey of the incidence of skin problems in a cohort of hospital staff during the COVID-19 pandemic: can this help plan future services?

  • Pages: 95-96
  • First Published: 06 July 2021
Free Access

CD08: Occupational dermatoses during the second COVID-19 pandemic wave: an audit of 401 healthcare workers

  • Page: 96
  • First Published: 06 July 2021
Free Access

CD09: A review of semi-virtual patch testing during the SARS-CoV-2 pandemic: practicalities and patient experience

  • Pages: 96-97
  • First Published: 06 July 2021
Free Access

CD10: Two cases of follicular allergic contact dermatitis following the use of cyanoacrylate surgical glue

  • Page: 97
  • First Published: 06 July 2021
Free Access

CD11: Flare-up phenomenon to LiquiBond (N-octyl cyanoacrylate): will this be a more frequent occurrence?

  • Pages: 97-98
  • First Published: 06 July 2021
Free Access

CD12: Hand care: it’s time to take the gloves off

  • Page: 98
  • First Published: 06 July 2021
Free Access

CD13: Contact allergy in discoid eczema

  • Page: 98
  • First Published: 06 July 2021
Free Access

CD14: Contact urticaria caused by the ultraviolet absorber ethylhexyl salicylate in sunscreens

  • Page: 99
  • First Published: 06 July 2021
Free Access

CD15: Comparison of photographic photonic assessment and conventional clinical assessment in diagnosis of contact allergy with patch testing: a pilot study

  • Page: 99
  • First Published: 06 July 2021
Free Access

CD16: Getting to the root of it: contact anaphylaxis from polyethylene glycol in a dental lubricant

  • Pages: 99-100
  • First Published: 06 July 2021
Free Access

CD17: Not always the healthier option: a case of exfoliative erythroderma secondary to ‘vegan’ soap

  • Page: 100
  • First Published: 06 July 2021
Free Access

CD18: Fragranced hand gels: beware the risk of contact allergy

  • Pages: 100-101
  • First Published: 06 July 2021
Free Access

CD19: Old allergen, new presentation: badge of honour

  • Page: 101
  • First Published: 06 July 2021
Free Access

CD20: Occupational dermatitis virtual clinic for healthcare workers: clinics to increase training opportunities to dermatology registrars who are working from home

  • Pages: 101-102
  • First Published: 06 July 2021
Free Access

CD21: Probable ‘baboon syndrome’ triggered by hormone replacement therapy

  • Page: 102
  • First Published: 06 July 2021
Free Access

CD22: A perplexing recurrent exfoliative eruption in a child

  • Page: 102
  • First Published: 06 July 2021

British Society for Dermatological Surgery

Free Access

DS01: Observational study of surgical-site infection in ulcerated skin cancers (OASIS)

  • Page: 103
  • First Published: 06 July 2021
Free Access

DS02: External referrals for Mohs micrographic surgery: reject, endorse or enforce ‘in-house review’ of histology slides?

  • Pages: 103-104
  • First Published: 06 July 2021
Free Access

DS03: Tissue processing in Mohs micrographic surgery: what is current UK practice?

  • Page: 104
  • First Published: 06 July 2021
Free Access

DS04: National survey of UK Mohs’ surgeons work practices

  • Pages: 104-105
  • First Published: 06 July 2021
Free Access

DS05: Two-thirds of patients may not require review after Mohs micrographic surgery

  • Page: 105
  • First Published: 06 July 2021
Free Access

DS06: Contending with COVID-19 in a Mohs micrographic surgery service

  • Page: 105
  • First Published: 06 July 2021
Free Access

DS07: Evaluation of telephone consultations prior to Mohs surgery: the importance of informed consent

  • Page: 106
  • First Published: 06 July 2021
Free Access

DS08: Exploring unmet needs and attitudes to skin self-examination in melanoma survivors: interim results

  • Pages: 106-107
  • First Published: 06 July 2021
Free Access

DS09 (P56): A systematic review and meta-analysis of total body photography for the diagnosis of cutaneous melanoma in adults

  • Page: 107
  • First Published: 06 July 2021
Free Access

DS10: Burow’s flap: a new reconstructive weapon in the dermatological surgeon’s armamentarium

  • Page: 107
  • First Published: 06 July 2021
Free Access

DS11: A complex multisubunit repair using three different flaps

  • Page: 108
  • First Published: 06 July 2021
Free Access

DS12: Replacing the need for skin grafting in small surgical excision wounds

  • Page: 108
  • First Published: 06 July 2021
Free Access

DS13: The FACE-Q questionnaire: long-term patient satisfaction with composite grafts for alar reconstruction

  • Page: 109
  • First Published: 06 July 2021
Free Access

DS14: Experience of using a scar-assessment tool to evaluate scars after Mohs surgery via virtual consultation during the COVID-19 pandemic

  • Page: 109
  • First Published: 06 July 2021
Free Access

DS15: Improving diagnostic accuracy of lichenoid keratosis using dermatoscopy

  • Page: 110
  • First Published: 06 July 2021
Free Access

DS16: The superiorly based reverse flow interpolated myocutaneous nasolabial flap to reconstruct a large defect of the alar nasi

  • Page: 110
  • First Published: 06 July 2021
Free Access

DS17: A pilot survey of sharps injuries among dermatology trainees in London centres

  • Pages: 110-111
  • First Published: 06 July 2021
Free Access

DS18: Porocarcinoma: a case series of 41 patients diagnosed over a 12-year period

  • Page: 111
  • First Published: 06 July 2021
Free Access

DS19: A full-thickness skin graft undergoes metaplasia to form a new lip vermillion border following surgical repair

  • Pages: 111-112
  • First Published: 06 July 2021
Free Access

DS20: Rising rates of melanoma in situ: a slowly growing problem?

  • Page: 112
  • First Published: 06 July 2021
Free Access

DS21: Silver nitrate-induced skin inflammation mimicking surgical infection

  • Pages: 112-113
  • First Published: 06 July 2021
Free Access

DS22: Establishing the use of total body photography by UK dermatologists

  • Page: 113
  • First Published: 06 July 2021
Free Access

DS23: A multicentre qualitative study of patients’ experience of skin surgery during the COVID-19 pandemic in the UK

  • Pages: 113-114
  • First Published: 06 July 2021
Free Access

DS24: Primary cutaneous mucinous adenocarcinoma: trends in incidence and management from the largest UK reported case series to date

  • Page: 114
  • First Published: 06 July 2021

Free Access

DS25: Pandemic pressures: the impact of COVID-19 on the 2-week-wait service at a regional skin oncology centre

  • Pages: 114-115
  • First Published: 06 July 2021
Free Access

DS26: COVID-19 and reduced detection of malignant melanoma in secondary dermatology services

  • Page: 115
  • First Published: 06 July 2021
Free Access

DS27: Outcomes in wound healing after lower leg skin surgery

  • Pages: 115-116
  • First Published: 06 July 2021
Free Access

DS28: Floater or heartsink? Recognizing tissue artefact in Mohs micrographic surgery

  • Page: 116
  • First Published: 06 July 2021
Free Access

DS29: Indications and outcomes for cutaneous squamous cell carcinomas treated with radiotherapy: a tertiary centre experience

  • Pages: 116-117
  • First Published: 06 July 2021
Free Access

DS31: Application of the Mohs micrographic surgery appropriate-use criteria at a UK teaching hospital: a prospective cohort study

  • Page: 117
  • First Published: 06 July 2021

British Society for Dermatopathology

Free Access

DP01: Histological spectrum of lesions that affect the anogenital mammary glands

  • Page: 118
  • First Published: 06 July 2021
Free Access

DP02: Diagnostic utility of the Pigmented Lesion Assay in an academic setting

  • Pages: 118-119
  • First Published: 06 July 2021
Free Access

DP03 (P32): Mucosal-associated invariant T cells and interleukin-17 lineage in hidradenitis suppurativa

  • Page: 119
  • First Published: 06 July 2021
Free Access

DP04: Utility of human oesophagus as a substrate for indirect immunofluorescence in pemphigus: a descriptive study

  • Page: 119
  • First Published: 06 July 2021
Free Access

DP05 (P43): Desmoplasia in cutaneous squamous cell carcinoma with perineural invasion

  • Page: 120
  • First Published: 06 July 2021
Free Access

DP06: Assessment of skin shave biopsies in the diagnosis of lentigo maligna: a 12-year study

  • Page: 120
  • First Published: 06 July 2021
Free Access

DP07: The plaguing plaques of progressive nodular non-Langerhans histiocytosis

  • Page: 121
  • First Published: 06 July 2021
Free Access

DP08: Leprosy unmasked by COVID-19 infection: a new diagnosis of leprosy with development of type 1 reversal reaction

  • Page: 121
  • First Published: 06 July 2021
Free Access

DP09: Blue rubber bleb naevus syndrome: an unusual case of a vascular anomaly presenting with a cutaneous manifestation and underlying gastrointestinal bleeding

  • Page: 122
  • First Published: 06 July 2021
Free Access

DP10: Case report of an antimelanoma differentiation-associated protein 5 antibody-associated amyopathic dermatomyositis

  • Pages: 122-123
  • First Published: 06 July 2021
Free Access

DP11: Preferentially expressed antigen in melanoma (PRAME): the holy grail in melanocytic pathology?

  • Page: 123
  • First Published: 06 July 2021
Free Access

DP12: Coma conundrum: a case of coma blisters in nonpressure-dependent areas

  • Page: 123
  • First Published: 06 July 2021
Free Access

DP13: Perniosis: a rare cutaneous manifestation of paroxysmal nocturnal haemoglobinuria

  • Page: 124
  • First Published: 06 July 2021
Free Access

DP14: Bruise-like cutaneous presentation of blastic plasmacytoid dendritic cell neoplasm: a rare and aggressive haematological malignancy

  • Page: 124
  • First Published: 06 July 2021
Free Access

DP15: Diffuse dermal angiomatosis of the breast in a 35-year-old woman with large pendulous breasts

  • Page: 125
  • First Published: 06 July 2021
Free Access

DP16: Severe, ulcerative cold panniculitis following COVID-19 infection

  • Page: 125
  • First Published: 06 July 2021
Free Access

DP17: Gluteal verrucous carcinoma arising within chronic hidradenitis suppurativa

  • Page: 126
  • First Published: 06 July 2021
Free Access

DP18: A case of secondary syphilis resembling erythema multiforme: how histopathology clues can avoid a delayed diagnosis

  • Pages: 126-127
  • First Published: 06 July 2021
Free Access

DP19: Transdifferentiation of chronic lymphocytic lymphoma to Langerhans cell sarcoma

  • Page: 127
  • First Published: 06 July 2021
Free Access

DP20: Reticular erythematous mucinosis: a rare case of primary dermal mucinosis

  • Page: 127
  • First Published: 06 July 2021
Free Access

DP21: Uncommon presentations of malignant melanoma: a diagnostic challenge

  • Page: 128
  • First Published: 06 July 2021
Free Access

DP22: Invasive mammary-type carcinoma arising in a patient with extramammary Paget disease of the scrotum

  • Pages: 128-129
  • First Published: 06 July 2021
Free Access

DP23: Melanocytic naevus

  • Page: 129
  • First Published: 06 July 2021
Free Access

DP24: Histology to the rescue for erupting erythematous nodules in a young patient

  • Pages: 129-130
  • First Published: 06 July 2021
Free Access

DP25: An interesting inflammatory rash masquerading as erythema elevatum diutinum

  • Page: 130
  • First Published: 06 July 2021

British Society for Paediatric Dermatology

Free Access

PA01: Paediatric Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective case series and evaluation of practice using the British Association of Dermatologists’ National Guidelines

  • Page: 131
  • First Published: 06 July 2021
Free Access

PA02: Phenotype association with filaggrin loss-of-function variants in 349 individuals with eczema from the Tower Hamlets Eczema Assessment (THEA)

  • Pages: 131-132
  • First Published: 06 July 2021
Free Access

PA03: Understanding phenotypic variations of pseudohypoparathyroidism and loss-of-function GNAS variants

  • Page: 132
  • First Published: 06 July 2021
Free Access

PA04 (P16): An assessment of the experiences of general practitioners and general practitioner trainees of referrals to paediatric dermatology services

  • Pages: 132-133
  • First Published: 06 July 2021

Free Access

PA05: Epidermolysis bullosa acquisita in children: a report of three cases

  • Page: 133
  • First Published: 06 July 2021
Free Access

PA06: The burden of treatment in paediatric atopic dermatitis: a mixed-methods study

  • Pages: 133-134
  • First Published: 06 July 2021
Free Access

PA07: Scratching the surface: a review of online misinformation and conspiracy theories in paediatric atopic dermatitis

  • Page: 134
  • First Published: 06 July 2021
Free Access

PA08: Rothmund–Thomson syndrome associated with cutaneous T-cell lymphoma

  • Page: 134
  • First Published: 06 July 2021
Free Access

PA09: Efficacy of an online educational video in improving parents’ knowledge of eczema management

  • Page: 135
  • First Published: 06 July 2021
Free Access

PA10: Written action plans to support the self-management of eczema: findings from an international review

  • Page: 135
  • First Published: 06 July 2021
Free Access

PA11: Bier anaemic spots, cyanosis and urticaria-like eruption (BASCULE) syndrome: a case series of four patients

  • Pages: 135-136
  • First Published: 06 July 2021
Free Access

PA12: Cost-effectiveness of emollients in UK patients with atopic dermatitis

  • Page: 136
  • First Published: 06 July 2021
Free Access

PA13: Two cases of amyopathic juvenile dermatomyositis associated with antitranscription intermediary factor 1 gamma autoantibodies

  • Pages: 136-137
  • First Published: 06 July 2021
Free Access

PA14: Emergency paediatric dermatology: a case series of Kasabach–Merritt syndrome

  • Page: 137
  • First Published: 06 July 2021
Free Access

PA15: Footprints in the snow: a rare case of metastatic Crohn disease of the scalp responsive to adalimumab

  • Pages: 137-138
  • First Published: 06 July 2021
Free Access

PA16: A case of rapidly involuting congenital haemangioma presenting as unilateral limb swelling

  • Page: 138
  • First Published: 06 July 2021
Free Access

PA17: Paediatric dermatology in a resource-limited setup

  • Pages: 138-139
  • First Published: 06 July 2021
Free Access

PA18: Longitudinal melanonychia with spontaneous resolution

  • Page: 139
  • First Published: 06 July 2021
Free Access

PA19: An unusual case of sweating: idiopathic localized unilateral hyperhidrosis in a 9-year-old and review of the literature

  • Page: 139
  • First Published: 06 July 2021
Free Access

PA20: Acquired partial lipoatrophy as the presenting feature of juvenile dermatomyositis

  • Pages: 139-140
  • First Published: 06 July 2021
Free Access

PA21: Aplasia cutis congenita in dizygotic twin infants

  • Page: 140
  • First Published: 06 July 2021
Free Access

PA22: Acrodermatitis enteropathica: how communication skills can help

  • Pages: 140-141
  • First Published: 06 July 2021
Free Access

PA23: The use of Biobrane® in a paediatric patient with toxic epidermal necrolysis: looking beyond the burn

  • Page: 141
  • First Published: 06 July 2021

British Society for Skin Care in Immunosuppressed Individuals

Free Access

BI01: Intravenous cidofovir treatment of severe giant molluscum contagiosum presenting with myiasis

  • Page: 142
  • First Published: 06 July 2021
Free Access

BI02: Melanized (dematiaceous) fungal infections simulating skin cancer in African organ transplant recipients

  • Pages: 142-143
  • First Published: 06 July 2021
Free Access

BI03: Phaeohyphomycosis of the leg caused by Exophiala oligosperma

  • Page: 143
  • First Published: 06 July 2021
Free Access

BI04: Lunar landscape of the leg

  • Pages: 143-144
  • First Published: 06 July 2021
Free Access

BI05 (P18): Audit of infectious complications in erythrodermic mycosis fungoides/Sézary syndrome

  • Page: 144
  • First Published: 06 July 2021
Free Access

BI06 (P42): Decreased risk of rheumatic skin diseases in HIV/AIDS

  • Pages: 144-145
  • First Published: 06 July 2021
Free Access

BI07: The effect of the COVID-19 pandemic on immunosuppressed patients undergoing skin surveillance

  • Page: 145
  • First Published: 06 July 2021
Free Access

BI08: Remote management of immunotherapy-induced bullous pemphigoid during the COVID-19 pandemic

  • Pages: 145-146
  • First Published: 06 July 2021
Free Access

BI09: Immune dysfunction in primary lymphoedema

  • Page: 146
  • First Published: 06 July 2021
Free Access

BI10: Skin surveillance in immunocompromised organ transplant recipients: developing a regional protocol

  • Pages: 146-147
  • First Published: 06 July 2021
Free Access

BI11: Donor-transmitted melanoma with fatal outcomes in three transplant recipients: the importance of national guidelines in minimizing risk

  • Page: 147
  • First Published: 06 July 2021
Free Access

BI12: Cutaneous presentation of donor-derived acute myeloid leukaemia following haploidentical stem cell transplantation for human T-cell lymphotropic virus type-1 adult T-cell leukaemia/lymphoma

  • Pages: 147-148
  • First Published: 06 July 2021
Free Access

BI13: An audit to review the uptake of recommended vaccinations in patients with psoriasis prescribed immunosuppressing medications

  • Page: 148
  • First Published: 06 July 2021
Free Access

BI14: Multiple autoimmune bullous disorders arising secondary to immune checkpoint blockade

  • Pages: 148-149
  • First Published: 06 July 2021
Free Access

BI15: Widespread pediculosis pubis infestation associated with natalizumab

  • Page: 149
  • First Published: 06 July 2021
Free Access

BI16: Cutaneous mycosis mimicking dermatofibrosarcoma protuberans

  • Page: 149
  • First Published: 06 July 2021
Free Access

BI17: Opportunistic fungal infection with Alternaria in the immunosuppressed

  • Page: 150
  • First Published: 06 July 2021
Free Access

BI18: Mycobacterium marinum bacteraemia: a complication worth fishing for

  • Pages: 150-151
  • First Published: 06 July 2021
Free Access

BI19: Eczema herpeticum in a patient with severe combined immunodeficiency

  • Page: 151
  • First Published: 06 July 2021
Free Access

BI20: Biological documentation in primary care: a review from the dermatology department of a Welsh hospital

  • Page: 151
  • First Published: 06 July 2021
Free Access

BI21: Targeted chemotherapy-induced psoriasis successfully treated with acitretin

  • Pages: 151-152
  • First Published: 06 July 2021
Free Access

BI22: A three-patient case series: methotrexate-induced nasal septal perforation, mucositis and widespread ulceration

  • Page: 152
  • First Published: 06 July 2021
Free Access

BI23: Natalizumab-induced acquired perforating dermatosis

  • Pages: 152-153
  • First Published: 06 July 2021
Free Access

BI24: Reimbursement systems as a barrier to sunscreen use for organ transplant recipients in Ireland: a community pharmacist survey

  • Page: 153
  • First Published: 06 July 2021
Free Access

BI25: Lessons learnt: our experience of a specialist surveillance dermatology clinic for immunosuppressed patients at a UK tertiary centre

  • Pages: 153-154
  • First Published: 06 July 2021
Free Access

BI26: Extramammary Paget disease manifesting in a patient with severe hidradenitis suppurativa

  • Page: 154
  • First Published: 06 July 2021
Free Access

BI27: Skin cancer awareness in liver transplant recipients in Ireland: an answer to a burning question

  • Pages: 154-155
  • First Published: 06 July 2021
Free Access

BI28: Immune reconstitution syndrome following discontinuation of long-term azathioprine for ulcerative colitis

  • Page: 155
  • First Published: 06 July 2021
Free Access

BI29: Case series of vasculitis, iron deficiency anaemia and lymphopenia in patients with scurvy

  • Pages: 155-156
  • First Published: 06 July 2021
Free Access

BI30: A bullous dilemma

  • Page: 156
  • First Published: 06 July 2021

Dermatology Teachers

Free Access

DT01: Barriers to and facilitators of implementation of the dermatology curriculum across UK medical schools: results of a national survey and recommendations

  • Page: 157
  • First Published: 06 July 2021
Free Access

DT02: What has been the impact of COVID-19 redeployment on dermatology trainees’ professional identity? An interpretative phenomenological study

  • Pages: 157-158
  • First Published: 06 July 2021
Free Access

DT03: Diversifying educational resources during the COVID-19 pandemic: delivering educational dermatology podcasts and webinars for healthcare professionals

  • Page: 158
  • First Published: 06 July 2021
Free Access

DT04: Pandemic placement: delivering the dermatology undergraduate curriculum at a UK medical school during the COVID-19 crisis

  • Pages: 158-159
  • First Published: 06 July 2021
Free Access

DT05: Slack as a virtual undergraduate dermatology community: a pilot

  • Page: 159
  • First Published: 06 July 2021
Free Access

DT06: Skin of colour representation in dermatology and undergraduate medical textbook images: a meta-analysis

  • Pages: 159-160
  • First Published: 06 July 2021
Free Access

DT07: The impact of the COVID-19 pandemic on dermatology ST3 application preparation: a national survey of junior doctors in the UK

  • Page: 160
  • First Published: 06 July 2021

Historical Symposium

Free Access

H01: The haematoxylin and eosin stain: from piracy to pathology

  • Page: 161
  • First Published: 06 July 2021
Free Access

H02: The myth of the dhobie itch

  • Page: 161
  • First Published: 06 July 2021
Free Access

H03: Avicenna: prince of physicians

  • Page: 162
  • First Published: 06 July 2021
Free Access

H04: Moulage: the forgotten art of dermatology?

  • Page: 162
  • First Published: 06 July 2021
Free Access

H05: Pioneering wound treatment in a suffragette military hospital in World War 1

  • Page: 163
  • First Published: 06 July 2021
Free Access

H06: The high impact of skin disease on British forces in the Crimean War, 1854–56

  • Page: 163
  • First Published: 06 July 2021
Free Access

H07: Mr Chesebrough’s Wonder Jelly! A history of petrolatum and the skin

  • Pages: 163-164
  • First Published: 06 July 2021
Free Access

H08: Pemphix to pemphigus vulgaris: the journey to classifying blisters

  • Page: 164
  • First Published: 06 July 2021
Free Access

H09: From laboratory to clinic: the ‘retinoid project’

  • Pages: 164-165
  • First Published: 06 July 2021
Free Access

H10: Scleroderma or scleroedema? The complex classification of systemic sclerosis

  • Page: 165
  • First Published: 06 July 2021
Free Access

H11: British Association of Dermatologists’ historical abstracts: an unrivalled resource (284 abstracts by 393 authors)

  • Page: 165
  • First Published: 06 July 2021
Free Access

H12: ‘Keep your hair on!’ A historical narration of trichotillomania

  • Page: 166
  • First Published: 06 July 2021
Free Access

H13: ‘Baldness of the fanfares’: the historical link between music and hair loss

  • Page: 166
  • First Published: 06 July 2021
Free Access

H14: From antiquity to the present day: a brief history of balding

  • Page: 167
  • First Published: 06 July 2021
Free Access

H15: Lessons from Sushruta revealing the Ayurvedic ancestry of dermatology

  • Page: 167
  • First Published: 06 July 2021
Free Access

H16: Albert Sézary: the man behind the monster cells

  • Pages: 167-168
  • First Published: 06 July 2021

Psychodermatology UK

Free Access

PS01: Psychodermatology: challenges faced by UK dermatologists

  • Page: 169
  • First Published: 06 July 2021
Free Access

PS02: Experiences and understanding of body image dissatisfaction in individuals with a chronic dermatological condition: an interpretative phenomenological analysis

  • Page: 169
  • First Published: 06 July 2021
Free Access

PS03 (P39): Real-world disease characteristics and treatment patterns in patients with atopic dermatitis in the UK: results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey

  • Pages: 169-170
  • First Published: 06 July 2021
Free Access

PS04: Burden of treatment in adult patients with atopic dermatitis

  • Page: 170
  • First Published: 06 July 2021
Free Access

PS05: The role of disease severity and illness perceptions in predicting health outcomes in people with hidradenitis suppurativa: a longitudinal study

  • Page: 171
  • First Published: 06 July 2021
Free Access

PS06 (P38): Mental health of patients with psoriasis during the COVID-19 pandemic: a cross-sectional study in a tertiary setting

  • Pages: 171-172
  • First Published: 06 July 2021
Free Access

PS07 (P47): Improving treatment outcomes for leprosy in Pernambuco, Brazil: a qualitative study exploring the experiences and perceptions of retreatment patients and their carers

  • Page: 172
  • First Published: 06 July 2021
Free Access

PS08: The psychological impact of hair loss and the role of psychological interventions

  • Pages: 172-173
  • First Published: 06 July 2021
Free Access

PS09 (P50): A randomized controlled trial of integrative cognitive behavioural therapy for patients with alopecia areata: a pilot study

  • Page: 173
  • First Published: 06 July 2021
Free Access

PS10 (P58): A screening study of distress levels in patients attending a skin cancer clinic

  • Pages: 173-174
  • First Published: 06 July 2021
Free Access

PS11: Severe suicidal attempt secondary to allergic contact dermatitis in a noncompliant patient

  • Page: 174
  • First Published: 06 July 2021
Free Access

PS12: When is dermatitis artefacta not dermatitis artefacta?

  • Pages: 174-175
  • First Published: 06 July 2021

Teledermatology and Digital Dermatology Symposium

Free Access

BT01: A 5-year paediatric teledermatology experience: a retrospective follow-on study

  • Page: 176
  • First Published: 06 July 2021
Free Access

BT02: Teledermatology diagnostic accuracy and the role of full-body skin examination in an urban setting

  • Pages: 176-177
  • First Published: 06 July 2021
Free Access

BT03: Performance outcomes for and impact on the dermatology service of a medical photography-based store-and-forward model digitized teledermatology pathway with over 8000 patients in an urban setting

  • Page: 177
  • First Published: 06 July 2021
Free Access

BT04: A new virtual inpatient dermatology electronic referral service: a timely answer to reducing cross-contamination during the COVID-19 pandemic?

  • Page: 177
  • First Published: 06 July 2021
Free Access

BT05: Reducing face-to-face visits for skin cancer assessment using patient-led teledermatology: a retrospective review of experience with the MySkinSelfie platform

  • Page: 178
  • First Published: 06 July 2021
Free Access

BT06: Reporting time in two different teledermatology platforms

  • Page: 178
  • First Published: 06 July 2021
Free Access

BT07: ‘To see or not to see?’ That is the question: teleconsultations in primary care and the impact on 2-week-wait referrals and outcomes

  • Pages: 178-179
  • First Published: 06 July 2021
Free Access

BT08: Assessment of three different dermoscopy imaging systems during a fast-track skin cancer clinic

  • Page: 179
  • First Published: 06 July 2021
Free Access

BT09: Standard of patient-sent images in teledermatology 2-week-wait skin cancer clinics during the COVID-19 pandemic

  • Pages: 179-180
  • First Published: 06 July 2021
Free Access

BT10: Medical education in the COVID-19 era: a remote dermatology attachment

  • Page: 180
  • First Published: 06 July 2021
Free Access

BT11: Lesions in lockdown: mobile dermoscopy in virtual dermatology clinics

  • Pages: 180-181
  • First Published: 06 July 2021
Free Access

BT12: The environmental impact of teledermatology in the COVID-19 pandemic: a silver lining

  • Page: 181
  • First Published: 06 July 2021
Free Access

BT13: Teledermatology and the Montgomery rule of consent

  • Pages: 181-182
  • First Published: 06 July 2021
Free Access

BT14: Exploring the feasibility of a remote acne service: a report of a pilot study using the MySkinSelfie platform during the COVID-19 pandemic

  • Page: 182
  • First Published: 06 July 2021
Free Access

BT15: Evaluating paediatric dermatology telephone clinics during the COVID-19 pandemic in a UK cohort: a prospective study

  • Pages: 182-183
  • First Published: 06 July 2021
Free Access

BT16: Disaster-recovery modelling to shape services: a dermatology helpline as a telemedicine intervention during the initial surge of the COVID-19 pandemic

  • Page: 183
  • First Published: 06 July 2021
Free Access

BT17: Bridging the gap with Pando

  • Pages: 183-184
  • First Published: 06 July 2021
Free Access

BT18: A new era for teledermatology in the COVID-19 pandemic

  • Page: 184
  • First Published: 06 July 2021
Free Access

BT19: The use of a novel teledermatology/teledermoscopy service to maintain a dermatology cancer service in the midst of the COVID-19 pandemic

  • Page: 184
  • First Published: 06 July 2021
Free Access

BT20: A scoping review to identify the teaching methods that are employed in the education of telemedicine

  • Page: 185
  • First Published: 06 July 2021
Free Access

BT21: Virtual clinics in teledermatology: an opportunity for all?

  • Page: 185
  • First Published: 06 July 2021

Author Index

Free Access

Author Index

  • Pages: 186-192
  • First Published: 06 July 2021